Kei Fukami
- Clinical Biochemistry top 0.05%
- Endocrinology, Diabetes and Metabolism top 0.5%
- Nephrology top 0.5%
- Molecular Biology top 10%
- Physiology top 5%
- Co-authors
- Sho‐ichi YamagishiSeiya OkudaTakanori MatsuiSeiji UedaMark E. CooperJosephine M. ForbesMasayoshi TakeuchiKensei Taguchi
- Topics
- Advanced Glycation End Products research (52 papers)Chronic Kidney Disease and Diabetes (29 papers)Dialysis and Renal Disease Management (16 papers)
- Journals
- PLoS ONEDiabetesScientific Reports
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Kei Fukami
127 papers receiving 4.4k citations
Peers
Comparison fields: 5 of 123
- Clinical Biochemistry 2.0k
- Endocrinology, Diabetes and Metabolism 1.3k
- Nephrology 1.0k
- Molecular Biology 1.0k
- Physiology 719
Countries citing papers authored by Kei Fukami
This map shows the geographic impact of Kei Fukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kei Fukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kei Fukami more than expected).
Fields of papers citing papers by Kei Fukami
This network shows the impact of papers produced by Kei Fukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kei Fukami. The network helps show where Kei Fukami may publish in the future.
Co-authorship network of co-authors of Kei Fukami
This figure shows the co-authorship network connecting the top 25 collaborators of Kei Fukami. A scholar is included among the top collaborators of Kei Fukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kei Fukami. Kei Fukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 67 | |
| 3 | 8 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 12 | |
| 10 | 1 | |
| 11 | 29 | |
| 12 | 23 | |
| 13 | 18 | |
| 14 | 45 | |
| 15 | 31 | |
| 16 | 26 | |
| 17 | 13 | |
| 18 | 33 | |
| 19 | 25 | |
| 20 | 12 |
About Kei Fukami
Kei Fukami is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 135 papers that have together received 4.5k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (52 papers), Chronic Kidney Disease and Diabetes (29 papers) and Dialysis and Renal Disease Management (16 papers). The work is most often cited by research in Clinical Biochemistry (2.0k citations), Nephrology (1.0k citations) and Endocrinology, Diabetes and Metabolism (1.3k citations). Kei Fukami has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Sho‐ichi Yamagishi, Seiya Okuda, Takanori Matsui, Seiji Ueda, Mark E. Cooper, Josephine M. Forbes, Masayoshi Takeuchi, Kensei Taguchi, Yusuke Kaida and Sayaka Maeda. Their work appears in journals such as PLoS ONE, Diabetes and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.